Advertisement

agilon health, inc. AGL

Set alert

Price alert · AGL

All alert types
84.63 USD -0.27 -0.32%

As of Nov 2, 9:34 AM ET

Bid
82.05 × 300
Ask
85.66 × 300
83.78 Day range 86.12
7.48 52-week range 133.04
YTD
+391.18%
1 year
+324.85%
Open
84.31
Prev close
84.90
Mkt cap
1.42B
Vol
4.85K
Avg vol
255.27K
EPS
-15.41
P/E
0.00
Div yield
0.00%
More statistics
Low
83.78
High
86.12
Forward P/E
35.83
Beta
3.00
Short ratio
3.93
Inst. own
97.01%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
88.02
200-d avg
64.69
1y target
115.83

1D chart

Chart tools
Interval

Signals (21)
NameTimeAgo
RSI: Overbought4:00 PM2 days ago
RSI: Overbought3:54 PM2 days ago
RSI: Overbought3:47 PM2 days ago
SMA: Bullish3:24 PM2 days ago
SMA: Bullish3:22 PM2 days ago
MACD: Buy Signal3:06 PM2 days ago
RSI: Oversold2:48 PM2 days ago
MACD: Sell Signal2:17 PM2 days ago
SMA: Bearish2:09 PM2 days ago
SMA: Bullish2:08 PM2 days ago
SMA: Bearish2:00 PM2 days ago
SMA: Bearish2:00 PM2 days ago
SMA: Bullish1:48 PM2 days ago
SMA: Bullish1:48 PM2 days ago
MACD: Buy Signal1:47 PM2 days ago
SMA: Bearish12:45 PM2 days ago
SMA: Bearish12:44 PM2 days ago
SMA: Bullish12:39 PM2 days ago
SMA: Bearish12:37 PM2 days ago
MACD: Sell Signal12:31 PM2 days ago
SMA: Bullish11:10 AM2 days ago

Key statistics

Market cap
1.42B
Enterprise value
1.29B
Trailing P/E
0.00
Forward P/E
35.83
PEG ratio
0.00
Price / sales
0.24
Price / book
6.24
EPS (TTM)
-15.41
Beta
3.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-3.92%
Revenue (TTM)
5.92B
Revenue growth
7.20%
Free cash flow
-145.68M
Total cash
185.63M
Total debt
33.45M
Return on equity
-78.94%
Shares outstanding
16.79M
Short % of float
8.54%
50-day average
88.02
200-day average
64.69

Analyst view

Consensus: buy

Buy
Price target (mean) 115.83 +36.9% upside
Target (low)
85.00
Target (mean)
115.83
Target (high)
146.00
Ratings (0m) 15 5 buy · 9 hold · 1 sell
  • Strong buy0
  • Buy5
  • Hold9
  • Sell0
  • Strong sell1

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate -0.73.

Earnings history

Financials — quick view

All financials
AGL Revenue — quarterly 1.49B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
AGL Net income — quarterly 17.96M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
AGL EPS — quarterly 1.07
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

AGL recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 2026-1.23———
Aug 5, 2026Jun 30, 20260.1441.04+0.90+622.22%
May 6, 2026Mar 31, 20261.131.80+0.67+59.29%
Feb 25, 2026Dec 31, 2025-6.75-11.50-4.75-70.37%
Nov 4, 2025Sep 30, 2025-3.73-6.75-3.02-80.73%
Aug 5, 2025Jun 30, 2025-2.75-6.25-3.50-127.27%

Upgrades / downgrades

AGL analyst upgrades and downgrades
DateFirmActionFromTo
Sep 15, 2026BernsteinupMarket PerformOutperform
Aug 24, 2026JP MorganmainUnderweightUnderweight
Aug 11, 2026Wells FargomainOverweightOverweight
Aug 11, 2026CitigroupupSellNeutral
Aug 6, 2026Truist SecuritiesmainHoldHold
Aug 6, 2026BenchmarkmainBuyBuy

About agilon health, inc.

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on AGL — it syncs with the Stock Master app.

Insider holders

AGL insider holders
InsiderRelationLatest transactionDateShares held
GERTSCH TIMOTHYOfficerStock Award(Grant)Mar 31, 202614,324
MANSUKANI SHARAD S.DirectorStock Award(Grant)Jun 1, 202656,242
O'ROURKE TIMOTHY PATRICKChief Executive OfficerStock Award(Grant)May 6, 2026320,000
SCHWANEKE JEFFREY AChief Financial OfficerStock Award(Grant)Mar 31, 2026141,234
SELL STEVEN JChief Executive OfficerStock Award(Grant)Mar 31, 2025974,371
SHAKER BENJAMINOfficerStock Award(Grant)Mar 31, 2026123,525

Institution ownership

AGL institution ownership
Holder% heldSharesValueReported
Clayton, Dubilier & Rice, LLC23.82%4,000,000338.48MJun 29, 2026
Morgan Stanley11.98%2,011,196170.19MJun 29, 2026
North Peak Capital Management, Llc8.84%1,485,066125.67MJun 29, 2026
Blackrock Inc.6.83%1,146,52097.02MJun 29, 2026
AQR Capital Management, LLC4.12%692,54158.60MJun 29, 2026
Goldman Sachs Group Inc4.09%686,79258.12MJun 29, 2026

Fund ownership

AGL fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.20%369,63831.28MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.93%323,52027.38MSep 29, 2026
Morgan Stanley Insight Fund1.64%274,56623.23MJun 29, 2026
Brighthouse Funds Trust I-Morgan Stanley Discovery Portfolio1.47%246,72620.88MJun 29, 2026
MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio1.43%239,59320.27MJun 29, 2026
SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF1.15%193,11816.34MAug 30, 2026
Advertisement